肺结核合并糖尿病患者抗痨药物耐药影响因素的COX模型分析
发布时间：2018-12-11 16:19
【摘要】：正我国肺结核发病率呈升高趋势,国家卫生计生委将肺结核防控作为基本公共卫生服务重要内容之一~[1]。近年临床发现,糖尿病患者罹患肺结核,抗痨治疗效果较差,肺结核耐药情况较为严重,研究认为这与糖尿病患者抵抗力减低,细胞免疫受到抑制有关~[2]。因此,对糖尿病患者合并肺结核后抗痨药物耐药的相关危险因素进行深入研究,能有助于及早干
[Abstract]:The incidence of pulmonary tuberculosis is on the rise in China. The National Health and Family Planning Commission regards tuberculosis prevention and control as one of the important contents of basic public health services. In recent years, it has been found that patients with diabetes suffer from pulmonary tuberculosis, the effect of anti-tuberculosis treatment is poor, and the drug resistance of tuberculosis is more serious. It is considered that this is related to the decrease of resistance and inhibition of cellular immunity of diabetic patients. Therefore, in-depth study on the risk factors of anti-tuberculosis drug resistance in diabetic patients with pulmonary tuberculosis can be helpful for early dryness.
【作者单位】： 浙江省台州恩泽医疗集团路桥医院感染科;
【分类号】：R521;R587.1
，
本文编号：2372850
[Abstract]:The incidence of pulmonary tuberculosis is on the rise in China. The National Health and Family Planning Commission regards tuberculosis prevention and control as one of the important contents of basic public health services. In recent years, it has been found that patients with diabetes suffer from pulmonary tuberculosis, the effect of anti-tuberculosis treatment is poor, and the drug resistance of tuberculosis is more serious. It is considered that this is related to the decrease of resistance and inhibition of cellular immunity of diabetic patients. Therefore, in-depth study on the risk factors of anti-tuberculosis drug resistance in diabetic patients with pulmonary tuberculosis can be helpful for early dryness.
【作者单位】： 浙江省台州恩泽医疗集团路桥医院感染科;
【分类号】：R521;R587.1
，
本文编号：2372850
本文链接：https://www.wllwen.com/yixuelunwen/chuanranbingxuelunwen/2372850.html
最近更新
教材专著
